Atossa Therapeutics Inc (ATOS)
1.455
+0.04
(+3.19%)
USD |
NASDAQ |
Apr 23, 12:25
Atossa Therapeutics Cash from Investing (TTM): -0.014M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.014M |
September 30, 2023 | -2.022M |
June 30, 2023 | -4.727M |
March 31, 2023 | -4.714M |
December 31, 2022 | -4.727M |
September 30, 2022 | -2.719M |
June 30, 2022 | -0.022M |
March 31, 2022 | -0.022M |
December 31, 2021 | -0.009M |
September 30, 2021 | -0.0086M |
June 30, 2021 | -0.0024M |
March 31, 2021 | -0.009M |
December 31, 2020 | -0.009M |
September 30, 2020 | -0.0094M |
June 30, 2020 | -0.0066M |
March 31, 2020 | -0.0076M |
December 31, 2019 | -0.0076M |
September 30, 2019 | -0.0641M |
June 30, 2019 | -0.067M |
March 31, 2019 | -0.0598M |
December 31, 2018 | -0.1109M |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | -0.0092M |
September 30, 2016 | -0.1827M |
June 30, 2016 | -0.2117M |
March 31, 2016 | -0.2274M |
December 31, 2015 | -0.2884M |
September 30, 2015 | -0.1665M |
June 30, 2015 | -0.2339M |
March 31, 2015 | -0.3063M |
December 31, 2014 | -0.3433M |
September 30, 2014 | -0.3767M |
June 30, 2014 | -0.591M |
March 31, 2014 | -0.5843M |
December 31, 2013 | -0.4898M |
September 30, 2013 | -0.5353M |
June 30, 2013 | -0.2245M |
March 31, 2013 | -0.1431M |
December 31, 2012 | -0.1346M |
September 30, 2012 | -0.0517M |
June 30, 2012 | -0.0672M |
March 31, 2012 | -0.1369M |
December 31, 2011 | -0.1369M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-4.727M
Minimum
Dec 2022
-0.0024M
Maximum
Jun 2021
-1.009M
Average
-0.014M
Median
Dec 2023
Cash from Investing (TTM) Benchmarks
AngioDynamics Inc | 124.52M |
Biolase Inc | -1.129M |
Outset Medical Inc | 83.03M |
Perspective Therapeutics Inc | 24.37M |
Electromed Inc | -1.219M |